Skip to main content


International Journal of Clinical Oncology


International Journal of Clinical Oncology OnlineFirst articles

20.06.2022 | Original Article

Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405)

Epidermal growth factor receptor (EGFR) -tyrosine kinase inhibitors (TKIs) are the standard of care for the first-line treatment of advanced non-small-cell lung cancer (NSCLC) with sensitizing EGFR mutation [ 1 – 5 ]. However, no novel effective …

19.06.2022 | Original Article

Microsatellite instability in patients with hepato-biliary-pancreatic malignancies in clinical practice (KHBO 1903)

Recently, there has been remarkable progress in the development of pharmacotherapeutic cancer treatments such as immune checkpoint inhibitors (ICIs). ICIs include the anti-programmed cell death-1 (PD-1) antibody, anti-programmed cell death …

Open Access 18.06.2022 | Original Article

Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer

17.06.2022 | Original Article

Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors

Randomized clinical trials (RCTs) are best ways to establish new treatments. However, only a limited subset of patients may participate in these trials partially because of many defined inclusion and exclusion criteria [ 1 – 3 ]. While strict …

17.06.2022 | Original Article

Development of a national health policy logic model to accelerate the integration of oncology and palliative care: a nationwide Delphi survey in Japan

Cancer is the world’s leading cause of death, accounting for approximately 10.0 million deaths each year, and one in six deaths [ 1 ]. In addition, cancer is known to cause severe distress (e.g., physical, psychological and social) in patients and …

Aktuelle Ausgaben

Über diese Zeitschrift

The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

International Journal of Clinical Oncology
Volume 2/1997 - Volume 27/2022
Springer Nature Singapore
Elektronische ISSN
Print ISSN

Neu im Fachgebiet Onkologie


Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.